The effect of a six-month programme of intradialytic cycling on survival and hospitalisations in people requiring haemodialysis: 5-year follow-up of the CYCLE-HD randomised controlled trial
PLOS One · 2025
DOI: 10.1371/journal.pone.0332389 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2025. Verfasst von Sherna F Adenwalla und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, University of Leicester, Leicester United Kingdom. Hauptthemen laut MEDLINE: Renal Dialysis, Hospitalization, Kidney Failure, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research.
Abstract (Originalsprache)
We have previously shown that a six-month programme of intradialytic cycling (IDC) improved cardiovascular structure and function, it is unclear whether these changes are associated with long-term benefits. The aim of this post-trial analysis was to evaluate a programme of IDC on all-cause mortality, hospitalisations and cardiovascular events at five-years. Mortality and hospitalisation data were collected from Hospital Episode Statistics and death certificates. Models were fitted unadjusted and adjusted for age, sex, diabetes, duration of dialysis, and receiving a kidney transplant. Cox proportional hazard models were used for time-to-event analysis to evaluate all-cause mortality. Hospitalisations were analysed using a negative binomial regression model, and length of stay using a generalised linear model. A composite outcome of time to first cardiovascular event, combining cardiovascular mortality and hospitalisations, was evaluated using a Cox model. There was no evidence of a statistically significant effect of treatment allocation on survival (hazard ratio (HR) 1.09, 95% confidence interval (CI): 0.68–1.76, p = 0.71). After adjustment, results remained non-significant (HR 1.22, 95% CI: 0.74–2.01, p = 0.43). There was no evidence of a significant effect on all-cause hospitalisations for unadjusted ( p = 0.20) or adjusted (p = 0.25) models. Similar results are reported for cardiovascular hospitalisations ( p = 0.30 and p = 0.17). For time to first cardiovascular event there was no evidence of a statistically significant effect (HR 1.39, 95% CI: 0.79–2.72, p = 0.26). The main findings show no evidence that a six-month programme of IDC affected all-cause mortality, hospitalisations, cardiovascular events, or length of stay in hospital at five-years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiovascular Sciences, University of Leicester, Leicester United Kingdom.
- Department of Renal Medicine, University Hospitals of Leicester NHS Trust, Leicester United Kingdom.
- Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom.
- NIHR Leicester Biomedical Research Centre, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
- NIHR Applied Research Collaboration East Midlands, University of Leicester, Leicester, United Kingdom.
- Leicester British Heart Foundation Centre of Research Excellence, University of Leicester, Leicester, United Kingdom.
ORCID-Profile: Katherine L Hull, James O Burton, Daniel S March
Förderung
- National Institute for Health and Care Research
Zitieren
APA
Adenwalla, S. F., Worboys, H. M., Lawday, D., Gray, L. J., Hull, K. L., Churchward, D. R., Highton, P. J., Young, H. M. L., Graham-Brown, M. P. M., Burton, J. O., & March, D. S. (2025). The effect of a six-month programme of intradialytic cycling on survival and hospitalisations in people requiring haemodialysis: 5-year follow-up of the CYCLE-HD randomised controlled trial. PLOS One. https://doi.org/10.1371/journal.pone.0332389
Vancouver
Adenwalla SF, Worboys HM, Lawday D, Gray LJ, Hull KL, Churchward DR, et al. The effect of a six-month programme of intradialytic cycling on survival and hospitalisations in people requiring haemodialysis: 5-year follow-up of the CYCLE-HD randomised controlled trial. PLOS One. 2025. doi:10.1371/journal.pone.0332389
BibTeX
@article{Adenwalla2025,
author = {Adenwalla, Sherna F and Worboys, Hannah M and Lawday, Daniel and Gray, Laura J and Hull, Katherine L and Churchward, Darren R and Highton, Patrick J and Young, Hannah M L and Graham-Brown, Matthew P M and Burton, James O and March, Daniel S},
title = {The effect of a six-month programme of intradialytic cycling on survival and hospitalisations in people requiring haemodialysis: 5-year follow-up of the CYCLE-HD randomised controlled trial},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0332389}
}
EUVIMED